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34S Abstracts May Supplement 2013Conclusions: This largest study of IFAA demonstrates
that: 1. Acute complications did not occur in aneurysms
smaller than 3.5cm; repair criteria for asymptomatic FAA
should be changed to >3.5 cm 2. The presence of chronic
FAA thrombus should reduce the threshold for elective
repair. 3. Criteria for symptomatic FAA repair should
remain unchanged.
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Background: Transcatheter aortic valve replacement
(TAVR) has revolutionized treatments for patients with
severe symptomatic aortic valve stenosis. In 2011 FDA
approved TAVR for surgically inoperable patients, and in
2012 for surgical high risk patients. Currently randomized
trials are underway evaluating the efﬁcacy of TAVR for
surgical low risk patients. Similar to TEVAR, TAVR
requires navigation of 22-25Fr sheaths and catheters across
the aortoiliac segments and expose patients to the risks of
arterial injury, bleeding, and stroke. As vascular surgeons
we have participated in nearly 100 TAVR procedures, and
can attest to the importance of vascular surgeons involve-
ment in not only limiting patient risks, but also in expanding
the indications for patients with critical aortic stenosis and
no other treatment options, as well as in managing bailouts
following complications of these procedures.
Technical Description: This video presentation will
focus on the implications of appropriate access during
TAVR. Tips and tricks to the bailout procedures needed
during misplaced aortic valves that require retrieval, as
well as diagnosis and treatments for arterial injury during
trans-femoral and trans-apical TAVR.
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Objectives: Acute limb ischemia (ALI) in pediatric
patients is rare but may lead to limb loss and life-long
complications. The aim of this study was to review the
experience of a Canadian tertiary pediatric center with
the medical and operative management of ALI.
Methods: The charts of in-patients diagnosed with
acute upper or lower limb ischemia between 1999-2012
were reviewed. Patient demographics, arterial clot site and
etiology, intervention, anticoagulation type and duration,
and short and long-term complications were analyzed.
Results: 136 patients presented with signs of limb
ischemia (46% female, 34% younger than 30 days, 51%
between 1-12 months, and 15% between 1-18 years). 95%
involved the lower limbs. 85% of arterial clots were totally
occlusive. 92% were due to vessel catheterization, 5% were
idiopathic, and 2% were due to hereditary hypercoagulable
states. 96% were managed nonoperatively. Patients were
treated with a combination of thrombolysis, unfractionated
or low molecular-weight heparin, aspirin and/or warfarin
(duration, 1 day-13 years). All patients were followed postdi-
scharge at our institution or at their referring hospital (average,
3.5 years). 13%had complications related toALIor anticoagu-
lation (limb length or thigh circumference discrepancy, or
intracranial hemorrhage). 25 patients died of unrelated causes
(sepsis, multi-organ dysfunction, or cardiac failure).
Conclusions: In contrast with adults, ALI in children
can generally be managed nonoperatively with anticoagula-
tion, likely because of their greater ability to develop arte-
rial collaterals. Long-term follow-up by a multidisciplinary
team of pediatric and surgical specialists and allied health
professionals is integral to achieving a successful outcome.
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The Positive Effect of Reentry Device With
Intravascular Ultrasound on Technical Success, Safety
and Patency of Subintimal Angioplasty of Chronic
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